High-Dose Thiamine Improves Fatigue After Stroke: A Report of Three Cases

被引:12
|
作者
Costantini, Antonio [1 ]
Pala, Maria Immacolata [1 ]
Catalano, Maria Lucia [1 ]
Notarangelo, Cristiano [1 ]
Careddu, Pamela [1 ]
机构
[1] Clin Villa Immacolata, Dept Neurol Rehabil, I-01100 Viterbo, Italy
关键词
POSTSTROKE FATIGUE;
D O I
10.1089/acm.2013.0461
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background and objectives: A previous study on fatigue and related disorders in inflammatory bowel disease, patients improved after therapy with high-dose thiamine. Chronic fatigue that accompanies inflammatory and autoimmune diseases could be the clinical manifestation of a mild thiamine deficiency, probably due to a dysfunction of intracellular transport or enzymatic abnormalities. Fatigue is a common symptom after stroke. Some studies show a severe functional effect of this symptom, as well as a high mortality rate. Necrotic cell death after cerebral ischemia triggers the activation of the immune system, followed by an inflammatory response. It is likely that fatigue related to stroke could benefit from high-dose thiamine. Consequently, the authors began treating poststroke patients with oral or parenteral high-dose thiamine. Design: Case study. Materials and methods: Three patients with stroke who also experienced fatigue were recruited. Severity of the fatigue was assessed by using the Fatigue Severity Scale. Blood free thiamine and thiamine pyrophosphate levels were within the healthy reference range in all the patients. Oral or parenteral therapy with high-dose thiamine was started. Results: The therapy led to an appreciable improvement of fatigue. Conclusion: This observation suggests that poststroke fatigue and related disorders could be the manifestation of mild thiamine deficiency due to a dysfunction of intracellular transport of thiamine or to structural enzymatic abnormalities.
引用
收藏
页码:683 / 685
页数:3
相关论文
共 50 条
  • [41] HIGH-DOSE THIAMINE PARTIALLY REVERSES SCOPOLAMINE-INDUCED COGNITIVE DEFICITS
    MEADOR, KJ
    ALLEN, ME
    FRANKE, P
    MOORE, EE
    LORING, DW
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 291 - 291
  • [42] HIGH-DOSE METHYLPREDNISOLONE TREATMENT IN EXPERIMENTAL FOCAL STROKE
    SLIVKA, A
    MURPHY, E
    HORROCKS, L
    NEUROLOGY, 1993, 43 (04) : A365 - A366
  • [44] High-dose tirilazad for acute stroke (RANTTAS II)
    Haley, EC
    STROKE, 1998, 29 (06) : 1256 - 1257
  • [45] Acute stroke with high-dose intravenous immune globulin
    White, David A.
    Leonard, Mandy C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (15) : 1611 - 1614
  • [46] Three Cases of Hemodialysis Patients Receiving High-Dose Ceftriaxone: Serum Concentrations and Its Neurotoxicity
    Inoue, Yui
    Doi, Yohei
    Arisato, Tetsuya
    Sugioka, Sayaka
    Koga, Kenichi
    Nishioka, Keisuke
    Sugawara, Akira
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (05): : 984 - 987
  • [47] Single, High-Dose Local Injection of bFGF Improves Thyroarytenoid Muscle Atrophy After Paralysis
    Goto, Takao
    Ueha, Rumi
    Sato, Taku
    Fujimaki, Yoko
    Nito, Takaharu
    Yamasoba, Tatsuya
    LARYNGOSCOPE, 2020, 130 (01): : 159 - 165
  • [48] Use of Cerebrolysin in combination with high-dose aspirin antithrombotic treatment of ischemic stroke: A case report
    Borisevich, Alexander
    Veremeyuk, Konstantin
    CLINICAL CASE REPORTS, 2021, 9 (09):
  • [49] Chronic fatigue in prostate cancer patients after radical prostatectomy (RP) or high-dose radiotherapy
    Kyrdalen, A. E.
    Hernes, E.
    Fossa, S. D.
    Dahl, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Contralateral Weakness and Fatigue After High-Dose Botulinum Toxin Injection for Management of Poststroke Spasticity
    Varghese-Kroll, Elizabeth
    Elovic, Elie P.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2009, 88 (06) : 495 - 499